ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$285.19
Tradestie Score
44
Market Cap
$431.71B
P/E Ratio
80.5
Revenue Growth
0.1%
Analyst Upside
-0.6%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1306.69
|
$739.95B | 43.1 | 27 | Compare |
|
JNJ
Johnson & Johnson
|
$267.61
|
$448.07B | 39.1 | 59 | Compare |
|
NVO
Novo-Nordisk A/S
|
$39.43
|
$262.92B | 9.6 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$172.57
|
$261.56B | 25.2 | 46 | Compare |
|
NVS
Novartis AG
|
$156.27
|
$254.99B | 23.3 | 36 | Compare |
|
ABT
Abbott Laboratories
|
$102.51
|
$232.30B | 37.4 | 50 | Compare |
|
MRK
Merck & Co., Inc.
|
$147.24
|
$225.13B | 119.0 | 43 | Compare |
|
AMGN
Amgen Inc
|
$447.28
|
$160.70B | 27.2 | 35 | Compare |
|
PFE
Pfizer Inc.
|
$30.42
|
$154.70B | 39.3 | 35 | Compare |
|
GILD
Gilead Sciences Inc
|
$157.19
|
$137.92B | - | 43 | Compare |
More ABBV Analysis
Data updated: Oct 22, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry